New studies reveal that optical genome mapping (OGM) can detect chromosomal abnormalities linked to recurrent pregnancy loss, ...

Pregnancy loss affects up to 25% of pregnancies. New studies using optical genome mapping reveal genetic and fragile-site ...

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or ...

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

Microarray testing can only be performed on an amniocentesis or CVS. These tests are more advanced than NIPT and are capable of looking at chromosomes to find out if any of them are missing a small ...

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

With rapid advancements in whole genome sequencing, Kadam noted that genetic science is moving toward even more comprehensive ...

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions ...